Skip to content

Eight EAC partner states

Chapter 30 · Pharmaceutical products

Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Other

3002.49.00

Simulate duties and taxes for this line Follow chapter 30
Line status
Official
Reference
EAC CET 2022, Schedule 1
Customs duty
0%
Category 0 · raw materials and capital goods
VAT
Customs value and duties collected, excluding VAT
Excise duty
0
Does not apply to this line
Statistical unit
kg
In force since 1 July 2022

Import duties and taxes

All duties and taxes collected when importing these goods, for an origin outside the EAC. Flat amounts depend on the weight or the number of containers.

Simulate duties and taxes
Import duties and taxes
Duty or tax Rate Base Status
DD Import duty (EAC CET) Indicative Exempt for EAC origin
Details

The applicable rate depends on which EAC CET band the tariff line falls into (0%, 10%, 25% or 35%). There is no single rate: see the simulator and the detailed tariff by HS code.

 0% Customs value Indicative
VAT Value added tax (national) Indicative
Details

VAT is a national tax, not an EAC-wide levy: its rate varies by the member state where the import is cleared (for example 16% in Kenya, 18% in Tanzania, Uganda and Rwanda, as of publication). No single rate is applied here: verify the current rate with the relevant national revenue authority before relying on any estimate.

 not quantified Customs value and duties collected, excluding VAT Indicative

Other lines of heading 3002

  • 3002.12.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Antisera and other blood fractions 0%
  • 3002.13.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale 0%
  • 3002.14.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, mixed, not put up in measured doses 0%
  • 3002.15.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, put up in measured doses or in forms 0%
  • 3002.41.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Vaccines for human medicine 0%
  • 3002.42.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Vaccines for veterinary medicine 0%
  • 3002.51.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Cell cultures, whether or not modified — Cell therapy products 0%
  • 3002.59.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Cell cultures, whether or not modified — Other 0%
  • 3002.90.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Other 0%
Sources 2
  1. 01

    EAC Common External Tariff, 2022 version (Schedules 1 and 2) (new tab), EAC Secretariat, institutional repository

    Accessed on

  2. 02

    East African Community, Customs Union (new tab), East African Community (eac.int)

    Accessed on